Skip to main content

Effect of Bifidobacterium longum 35624® on IBS

0.5 CPD learning hours

Effect of Bifidobacterium longum 35624® on irritable bowel syndrome severity and quality of life. Results of the Floravie observational study with Prof Jean-Marc Sabate

In this short webinar recorded for the 2021 British Society of Gastroenterology Annual Meeting, Prof Eamonn Quigley provides an update on definitions and pathophysiology associated with functional gastrointestinal disorders (FGIDs), and the latest research on probiotics for brain and gut health.

Learning Objectives:

  • Understand how symptom severity is measured in those with IBS according to Rome IV criteria

  • Understand the impact of Bifidobacterium longum 35624® on quality of life in those with IBS

  • Understand how stool transit is changed with the introduction and continued use of probiotics

  • Understand the role of probiotics as potential therapeutic strategy for improving quality of life and symptom severity in patients with IBS

We use cookies to ensure that we give you the best experience on our website. Please confirm you are happy to continue.